Endurant Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-527	Closed	-$386K	–	81
2018 Q2	$386K	Buy	+527	New	+$386K	0.17%	58
2017 Q4	–	Sell	-7,287	Closed	-$2.62M	–	85
2017 Q3	$2.62M	Buy	7,287 +4,434	+155%	+$1.6M	0.79%	45
2017 Q2	$837K	Buy	+2,853	New	+$837K	0.24%	72